Genomic Surveillance Reveals Emergence and Spread of Macrolide-Resistant <i>Mycoplasma pneumoniae</i> in Australia During the 2023–2024 Epidemic

Our findings demonstrate the utility of tNGS for genomic epidemiology and highlight the need for MRMP surveillance. Although macrolides remain effective in Australia, emerging MRMP strains require close monitoring to inform treatment guidelines and antimicrobial stewardship.